TF-505

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTF-505
Drug Alias NameFK-687FR-146687TF-505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase 2 inhibitorsSteroid 5 alpha reductase 1 inhibitors
TargetsSteroid 5 alpha reductase 2Steroid 5 alpha reductase 1
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A